6-169704017-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000339209.9(PHF10):āc.1483A>Cā(p.Ser495Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000131 in 152,254 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 33)
Consequence
PHF10
ENST00000339209.9 missense
ENST00000339209.9 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 6.05
Genes affected
PHF10 (HGNC:18250): (PHD finger protein 10) This gene contains a predicted ORF that encodes a protein with two zinc finger domains. The function of the encoded protein is not known. Sequence analysis suggests that multiple alternatively spliced transcript variants are derived from this gene but the full-length nature of only two of them is known. These two splice variants encode different isoforms. A pseudogene for this gene is located on Xq28. [provided by RefSeq, Jul 2008]
C6orf120 (HGNC:21247): (chromosome 6 open reading frame 120) This gene encodes a conserved, N-glycosylated protein that likely functions in the cellular response to endoplasmic reticulum stress. This protein is able to induce apoptosis in vitro in CD4+ T-cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28822368).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF10 | NM_018288.4 | c.1483A>C | p.Ser495Arg | missense_variant | 12/12 | ENST00000339209.9 | NP_060758.2 | |
C6orf120 | NM_001029863.3 | c.*982T>G | 3_prime_UTR_variant | 1/1 | ENST00000332290.4 | NP_001025034.1 | ||
PHF10 | NM_133325.3 | c.1477A>C | p.Ser493Arg | missense_variant | 12/12 | NP_579866.2 | ||
C6orf120 | NM_001317342.2 | c.*982T>G | 3_prime_UTR_variant | 2/2 | NP_001304271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHF10 | ENST00000339209.9 | c.1483A>C | p.Ser495Arg | missense_variant | 12/12 | 1 | NM_018288.4 | ENSP00000341805 | ||
PHF10 | ENST00000621772.4 | c.1342A>C | p.Ser448Arg | missense_variant | 12/12 | 1 | ENSP00000484117 | P1 | ||
C6orf120 | ENST00000332290.4 | c.*982T>G | 3_prime_UTR_variant | 1/1 | NM_001029863.3 | ENSP00000346931 | P1 | |||
PHF10 | ENST00000366780.8 | c.1477A>C | p.Ser493Arg | missense_variant | 12/12 | 5 | ENSP00000355743 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
152254
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74396
GnomAD4 genome
AF:
AC:
2
AN:
152254
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.1483A>C (p.S495R) alteration is located in exon 12 (coding exon 12) of the PHF10 gene. This alteration results from a A to C substitution at nucleotide position 1483, causing the serine (S) at amino acid position 495 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Uncertain
Sift
Pathogenic
D;D;.
Sift4G
Benign
T;T;T
Polyphen
B;B;.
Vest4
MutPred
0.33
.;Gain of solvent accessibility (P = 0.0023);.;
MVP
MPC
0.84
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at